openPR Logo
Press release

Otezla Moa Drug Insight Classificiations Market Research Report by Valuates Reports

06-06-2019 01:45 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Otezla Moa Drug Insight Classificiations Market Research

Apremilast, brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. It may also be useful for other immune system related inflammatory diseases.

The report covers the Global Market Assessment of the Otezla covering the historical global sales and also provides the Otezla sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Otezla and emerging therapies in this space.

View Full Report: https://reports.valuates.com/sreport/DELV-DRIN-05/Otezla_Drug_Insight_2019

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• A review of the Otezla, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Inquire for sample: https://reports.valuates.com/request/sample/DELV-DRIN-05/Otezla_Drug_Insight_2019

Reasons to Buy

• Establish a comprehensive understanding of Otezla
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Otezla`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Otezla with DelveInsight`s SWOT analysis

Inquire for Discount: https://reports.valuates.com/request/inquiry/DELV-DRIN-05/Otezla_Drug_Insight_2019

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1 (425) 388-2538
For IST Call +91-8040957137

To know more visit us on:

Website: reports.valuates.com/
Linkedin: www.linkedin.com/company/valuatesreports
Facebook: www.facebook.com/valuatesreports
Twitter: www.twitter.com/valuatesreports
Instagram: www.instagram.com/reportsvaluates
Youtube: www.youtube.com/channel/UCH4wNXynaTZbiD5m92WQI4A

Our aim is to collate unparalleled Market insights and notify our customers as and when it happens. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of silicon valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Otezla Moa Drug Insight Classificiations Market Research Report by Valuates Reports here

News-ID: 1766767 • Views:

More Releases from Valuates Reports

AI-Powered Pathology Market Size, Revenue Share, Insights & Future Outlook
AI-Powered Pathology Market Size The global market for AI-Powered Pathology was valued at US$ 184 million in the year 2023 and is projected to reach a revised size of US$ 382 million by 2030, growing at a CAGR of 11.7% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-33C18563/Global_AI_Powered_Pathology_Market_Research_Report_2024?utm_source=openpr&utm_medium=referral By Type • Automated Image Analysis • Disease Classification • Predictive Modeling By Application • Hospital • Diagnostic Centers • Laboratories & Research Institutes Key Companies Indica Labs, Aignostics, Deep Bio, Mindpeak, Paige AI, DoMore Diagnostics, Visiopharm, Sonrai Analytics, Stratipath,
AI In Clinical Trials Market Size, Revenue Share, Insights & Future Outlook
AI In Clinical Trials Market Size The global market for AI In Clinical Trials was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 6.8% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29K15279/Global_AI_In_Clinical_Trials_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral By Type • Software • Service By Application • Pharmaceutical and Biotechnology Companies • Contract Research Organization Key Companies Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC,
Forensic Accounting Services Market Size, Revenue Share, Insights & Future Outlo …
Forensic Accounting Services Market The global Forensic Accounting Services market was valued at US$ 19930 million in 2022 and is anticipated to reach US$ 31160 million by 2029, witnessing a CAGR of 7.7% during the forecast period 2023-2029. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1E9323/Global_Forensic_Accounting_Services_Market_Size_Status_and_Forecast_2022?utm_source=openpr&utm_medium=referral In general, forensic accounting services entail using the specialized expertise and investigative abilities that CPAs possess to gather, examine, and assess the evidence as well as to interpret and convey conclusions
Dental Anesthesia Market Size, Revenue Share, Insights & Future Outlook
Dental Anesthesia Market The global market for Dental Anesthesia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8V13175/Global_Dental_Anesthesia_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral By Type • Articaine • Lidocaine • Mepivacaine • Bupivacaine • Prilocaine • Others By Application • Carpool/Cartridges • Ampoules • Vials Key Companies Laboratorios Inibsa, Pierre Pharma, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply, Fresenius-Kabi The Dental Anesthesia Market is experiencing steady market growth as dental care

All 5 Releases


More Releases for Otezla

PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion …
DelveInsight's PDE4 Inhibitor Market Report Reveals Significant Growth Through 2034, Led by Arcutis Biotherapeutics, Pfizer, Shionogi, Palisade Bio, UNION Therapeutics, Amgen, and Chiesi Farmaceutici with Key Assets Including ZORYVE, EUCRISA, OTEZLA, Zatolmilast, and PALI-2108 Across Multiple Inflammatory Conditions. DelveInsight Business Research's extensive market analysis titled "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/phosphodiesterase-4-pde4-inhibitor-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]," provides a comprehensive insights into this rapidly evolving therapeutic class across
Behcet's Disease Pipeline: Advancing Innovation with 4+ Leading Companies Develo …
The Behcet's disease market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Bristol-Myers Squibb, Hoffmann-La Roche, Novartis Pharmaceuticals, Abbott, Sanguine Biosciences, and GlaxoSmithKline. These industry pioneers are transforming treatment strategies and redefining the future of Behcet's Disease, bringing new hope to patients worldwide. DelveInsight's "Behcet's Disease Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Behcet's Disease market.
Mild To Moderate Plaque Psoriasis Market: Analysis of Epidemiology, Pipeline Pro …
Mild To Moderate Plaque Psoriasis emerging therapies such as INBRX-109, TIBSOVO (ivosidenib), and others are expected to boost the Mild To Moderate Plaque Psoriasis Market in the upcoming years. DelveInsight has launched a new report on "Mild To Moderate Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2032" that delivers an in-depth understanding of the Mild To Moderate Plaque Psoriasis, historical and forecasted epidemiology as well as the Mild To Moderate
Behçet's syndrome Market to Witness Growth by (2022-2032), Estimates DelveInsig …
Behçet's syndrome also known as Bycet disease is a rare chronic, relapsing and debilitating inflammatory multisystem disease of unknown etiology characterized by ulcers affecting the mouth and genitals, various skin lesions, and abnormalities affecting the eyes. DelveInsight's "Behçet syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Behçet syndrome, historical and forecasted epidemiology as well as the Behçet syndrome market trends in the United States, EU5
COVID-19 Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trial …
DelveInsight's "COVID-19 Pipeline Insight" report provides comprehensive insights about key companies and pipeline drugs in the COVID-19 pipeline landscapes. It comprises COVID-19 pipeline drug profiles, including clinical and non-clinical stage products. It also includes the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive COVID-19 pipeline products. To Know about COVID-19 Pipeline Report: https://www.delveinsight.com/report-store/covid-19-coronavirus-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the key takeaways of the COVID-19 Pipeline
Dermatological Drugs Market Report 2021-2031 - newly published
This new report will cover these areas: Forecasts by Disease (Psoriasis, Dermatitis, Acne, Skin Infections, Other Diseases), by Skin Infections Drugs (Bepanthen/Bepanthol, Protopic, Dermovate), by Psoriasis Drugs (Humira, Stelara, Enbrel, Remicade, Taltz, Otezla), by Dermatitis Drugs (Cubicin, Zyvox, Valtrex, Canesten, Lamisil, Other Dermatitis Drugs), by Route of Administration (Topical, Oral, Parenteral Administration) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Dermatological Drugs Companies AND COVID-19 Recovery Scenarios. What